Concepedia

Whitney Tamaki

WT

Statistics

Publications

14

Citations

954

H-Index

12

Active since

2019

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Chan Zuckerberg Initiative (United States)

Parker Institute for Cancer Immunotherapy

University of San Francisco

Whitney Tamaki is an author at University of California, San Francisco specializing in life sciences, immunology, and oncology.

ORCID

Publications per year

2019–2025

14

Publications

14

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

Shen Dong, Kamir J. Hiam-Galvez, Cody T. Mowery et al. · JCI Insight · 2021 · 221 citations · Full text

, , +13

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

Chien-Chun Steven Pai, John Huang, Xiaoqing Lu et al. · Immunity · 2019 · 135 citations

, , +17

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Erin F. Simonds, Edbert D Lu, O. Badillo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 112 citations · Full text

, , +17

Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir

Jason Neidleman, Xiaoyu Luo, Julie Frouard et al. · eLife · 2020 · 93 citations · Full text

, , +14

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Deborah R. Caswell, Philippe Gui, Manasi K. Mayekar et al. · Nature Genetics · 2023 · 87 citations · Full text

, , +17

1–5 of 14